TC Biopharm () (TCBPW)

AI Score

Unlock

0.01

0.00 (66.67%)

At close: Mar 21, 2025, 3:32 PM

TC Biopharm () Balance Sheet Statement

Financials in GBP. Fiscal year is undefined.

Fiscal Year	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	1M	980.96K	2.46M	2.46M	1.92M	-4.81M	4.81M	4.81M	6M	6M	1.57M	1.55M	287.99K	287.99K	748.01K	-956.5K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	9.62M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.91M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	-1	-8.09M	n/a	n/a	n/a	n/a	-1	n/a	n/a	n/a	n/a	-956.5K
Receivables	n/a	n/a	n/a	n/a	n/a	610.71K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	-610.71K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.49M	3.22M	1.18M	3.24M	n/a	-1	n/a	2.64M	n/a	3.82M	n/a	n/a	1.88M	1.88M	n/a	n/a
Total Current Assets	3.95M	4.2M	5.7M	5.7M	4.95M	4.81M	7.45M	7.45M	9.82M	9.82M	3.86M	2.77M	2.17M	2.17M	2.22M	956.5K
Property-Plant & Equipment	2.31M	2.45M	2.62M	2.62M	2.68M	2.68M	3.29M	3.29M	3.23M	3.23M	3.68M	3.91M	4.13M	4.13M	4.63M	n/a
Goodwill & Intangibles	605.21K	608.51K	615.17K	615.17K	599.75K	599.75K	553.02K	553.02K	520.55K	520.55K	483.58K	458.42K	452.21K	452.21K	423.84K	n/a
Total Long-Term Assets	2.92M	3.06M	3.23M	3.23M	3.28M	-4.81M	3.84M	3.84M	3.75M	3.75M	4.17M	4.37M	4.59M	4.59M	5.05M	-956.5K
Total Assets	6.87M	7.26M	8.93M	8.93M	8.23M	8.23M	11.29M	11.29M	13.57M	13.57M	8.02M	7.14M	6.75M	6.75M	7.27M	n/a
Account Payables	942.27K	1.93M	1.85M	1.85M	953.86K	953.86K	882.36K	882.36K	1.69M	1.69M	1.42M	1.37M	1.08M	1.08M	638.37K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	365.17K	488.19K	653.48K	653.48K	1.05M	1.05M	6.81M	4.93M	1.64M	1.64M	n/a	n/a
Other Current Liabilities	1.99K	1.99K	13.44K	2.9M	1.4M	3.12M	6.02M	7.63M	2.65M	5.99M	6.93M	4.26M	4.43M	4.43M	1.98M	n/a
Total Current Liabilities	3.53M	4.76M	4.75M	4.75M	4.56M	4.56M	9.16M	9.16M	8.72M	8.72M	20.58M	15.18M	7.15M	7.15M	4.19M	n/a
Long-Term Debt	n/a	1.42M	n/a	1.5M	n/a	1.66M	n/a	1.8M	n/a	1.96M	n/a	n/a	2.38M	2.38M	n/a	n/a
Other Long-Term Liabilities	n/a	-1.42M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.87M	n/a	2.36M	2.86M	2.86M	n/a	n/a
Total Long-Term Liabilities	1.34M	1.42M	1.5M	1.5M	1.66M	1.66M	1.8M	1.8M	3.83M	3.83M	4M	4.62M	5.24M	5.24M	6.43M	n/a
Total Liabilities	4.87M	6.18M	6.25M	6.25M	6.22M	6.22M	10.96M	10.96M	12.55M	12.55M	24.58M	19.8M	12.39M	12.39M	10.61M	n/a
Total Debt	1.65M	1.73M	1.5M	1.5M	2.15M	2.15M	2.45M	2.45M	3.01M	3.01M	15.87M	11.45M	4.02M	4.02M	2.58M	n/a
Common Stock	9.89K	6.39K	399.45K	399.45K	397.98K	397.98K	397.49K	397.49K	395.64K	395.64K	195.48K	1.78M	1.78M	1.78M	194.58K	n/a
Retained Earnings	-44.15M	-42.16M	-38.84M	-38.84M	-33.24M	-33.24M	-33.37M	-33.37M	-32.12M	-32.12M	-33.47M	-29.57M	-22.54M	-22.54M	-19.89M	n/a
Comprehensive Income	n/a	n/a	0.00	0.00	16.71M	331.26K	n/a	n/a	16.71M	16.71M	16.71M	0.00	n/a	n/a	16.35M	-2.54M
Shareholders Equity	2M	1.08M	2.69M	2.69M	2.01M	331.26K	331.26K	331.26K	1.02M	1.02M	-16.56M	-12.66M	-5.63M	-5.63M	-3.35M	-2.54M
Total Investments	n/a	n/a	n/a	n/a	n/a	9.62M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.91M